Home › Pain After Surgery › NCT06434233
Opioid Use After Laparoscopic Salpingectomy
A Randomized Control Trial for Opioid Use After Laparoscopic Salpingectomy
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Individuals with a fallopian tube (unilateral and/or bilateral) * Age 18 years old and above * Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure * Benign indications for salpingectomy/tubal sterilization * Agreeing to participate Exclusion Criteria: * Chronic pain syndromes patients including fibromyalgia * Patients currently on long-term (i.e. for more than three months) opioid use * Conversion to laparotomy * Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone * Salpingectomy that occurs in conjunction with a major Gyn surgery (i.e. hysterectomy, etc) * Salpingectomy performed for treatment of ectopic pregnancy * Patients with a history of gastritis and/or GI bleeding
About the study
The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids.
The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.
What is being tested
- Acetaminophen (drug)
- Ibuprofen (drug)
- Oxycodone (drug)
Sponsor: Johns Hopkins University · Participants: 38 · Started: Apr 25, 2024
Contact the study team
- Mostafa Borahay, MD · Phone: 4439970400
- Shannon Osborne, MD · Phone: 4105502786
Official record on ClinicalTrials.gov — NCT06434233
Locations in the U.S.
| Maryland | Johns Hopkins Bayview Medical Center, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.